Nasdaq Panel Grants Request to Continue Edible Garden Listing
The Nasdaq Hearings Panel has approved a continued listing for Edible Garden, subject to maintaining a minimum closing bid price of $1.00 per share through November 23, 2026, follo…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The Nasdaq Hearings Panel has approved a continued listing for Edible Garden, subject to maintaining a minimum closing bid price of $1.00 per share through November 23, 2026, follo…
Kidz AI Inc. authorized a 50% increase to its existing share repurchase program, raising the authorized value to $3.0 million to enhance shareholder value amid positive market resp…
SunPower posted a $12.5 million non-GAAP operating loss and saw quarterly revenue decline to $56 million. The company reaffirmed Q3 2026 operating income improvement expectations.
Commvault reported record subscription revenue and free cash flow for Q1 FY'27, with guidance raised for the full year. The company also inked a strategic partnership with Microsof…
InfuSystem announced it will report second quarter 2026 financial results and host an investor conference call on August 4, 2026.
XPLR Infrastructure reported strong second-quarter net income and adjusted EBITDA, while completing a $150 million buyout and fully repaying its $500 million convertible notes with…
Kiniksa reported Q2 revenue driven by ARCALYST and advanced KPL-387 into Phase 3, raising fiscal expectations.
Boeing generated $24.6 billion in Q2 revenue driven by higher deliveries, despite GAAP and core operating losses. The company reported record total backlog of $715 billion and posi…
Grace Therapeutics announced the FDA did not identify safety or efficacy deficiencies after a Type A meeting, clearing clinical pathways for GTx-104. The good news is offset by the…
Repligen reported 13% organic Q2 2026 revenue growth and raised its FY26 guidance, while announcing a definitive agreement to acquire BioLife Solutions.
S&P Global reported Q2 2026 revenue and earnings growth despite a pending Mobility division spin-off. Post-spin leadership emphasized operational focus and AI expansion.
Xylem Inc. reported second-quarter revenue of $2.3 billion and adjusted EPS of $1.46. The company raised its 2026 revenue outlook, citing strengthened demand from industrial and AI…
Core Scientific reported Q2 2026 revenue of $164.2 million and Net loss of $1.16 billion, primarily due to warrant revaluation, while announcing a strategic partnership with AMD fo…
Sherwin-Williams reported a 7.5% increase in consolidated net sales, which exceeded guidance and pushed adjusted diluted earnings per share estimates higher for the full year.
American Tower reported a 133.2% increase in net income to $888 million for Q2 2026, driven by strong leasing demand and operational excellence. The growth reinforces the company's…
Alkermes reported Q2 2026 revenues of $496.0 million and adjusted EBITDA of $139.2 million. The company also announced Blair Jackson will become CEO effective August 1, succeeding …
Institutional holdings report (13F-HR) filed by OP Asset Management Ltd.
Altimmune reported positive topline results from its Phase 2 trial of pemvidutide for alcohol use disorder, showing significant reductions in heavy drinking days and favorable safe…
JetBlue reported robust Q2 results with RASM growth and introduced a 2028 EPS target. Positive momentum supports the airline's strategy and profitability outlook.
IQVIA reported second-quarter 2026 revenue of $4.37 billion, up 8.7%, and raised full-year guidance. The company also revealed R&D Solutions booked a record $3.15 billion in net ne…